Isolation and Molecular Characterization of Circulating Melanoma Cells
Xi Luo(Harvard University), Daniel A. Haber(Howard Hughes Medical Institute), David T. Ting(Massachusetts General Hospital), Anya M. Kimura(Harvard University), Devarati Mitra(Brigham and Women's Hospital), Keith T. Flaherty(Cancer Research Center), Mai P. Hoang(Harvard University), Donald P. Lawrence(Massachusetts General Hospital), Brian W. Brannigan(Harvard University), Ben S. Wittner(Broad Institute), Shyamala Maheswaran(Massachusetts General Hospital), Shannon L. Stott(Shriners Hospitals for Children - Erie), Shiwei Pan(Harvard University), Lecia V. Sequist(Harvard University), Mehmet Toner(Center for Cancer Research), Marcus Bosenberg(Yale Cancer Center), David E. Fisher(Massachusetts General Hospital), Martin McMahon(University of Utah), Sridhar Ramaswamy(Harvard University), Ryan J. Sullivan(Dana-Farber Cancer Institute)
Cited by 109
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
|Science|2016|5.3k
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
|Nature|2009|4.2k